CEN Case Reports

, Volume 7, Issue 2, pp 268–273 | Cite as

Recurrence of crescentic IgA nephropathy after renal transplantation

  • Georgios ZagkotsisEmail author
  • Christina Vourlakou
  • Aristeidis Paraskevopoulos
  • Theofanis Apostolou
Case Report


IgA nephropathy (IgAN) is one of the most common recurrent glomerulonephritis after renal transplantation. Rarely, it is accompanied with the presence of crescents that leads to rapid deterioration of renal function and graft loss. We present a 54-year-old patient with IgAN that received a cadaveric kidney allograft, but developed biopsy proven recurrent IgAN 7 months after renal transplantation. He was treated with intravenous steroids and angiotensin-converting enzyme inhibitor and remission was achieved. 4 years later, he presented again with heavy proteinuria, hematuria and deterioration of renal function. Allograft biopsy revealed recurrent IgAN with crescents, which was successfully treated with pulse intravenous steroids and six monthly doses of intravenous cyclophosphamide. This regime resulted in long-term sustained remission with a stable functioning graft 3 years later. Although it is not an established treatment as in native kidneys, intravenous cyclophosphamide should probably be considered in kidney transplants with potentially reversible recurrent crescentic IgAN.


IgA nephropathy Renal transplantation Recurrent glomerulonephritis Crescents 


Compliance with ethical standards

Conflict of interest

The authors have declared that no Conflict of interest exists.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.


  1. 1.
    Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–14. Scholar
  2. 2.
    D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24(3):179 – 96.CrossRefPubMedGoogle Scholar
  3. 3.
    Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol. 2004;24(3):287 – 91.CrossRefPubMedGoogle Scholar
  4. 4.
    Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Ame Soc Nephrol. 2010;5(12):2363–72. Scholar
  5. 5.
    Cosio FG, Cattran DC. Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation. Kidney Int. 2017;91(2):304 – 14. Scholar
  6. 6.
    Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, et al. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461–9. Scholar
  7. 7.
    Kowalewska J, Yuan S, Sustento-Reodica N, Nicosia RF, Smith KD, Davis CL, et al. IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis. 2005;45(1):167 – 75.CrossRefPubMedGoogle Scholar
  8. 8.
    Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164–77. Scholar
  9. 9.
    Jeong HJ, Kim YS, Kwon KH, Kim SI, Kim MS, Choi KH, et al. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Pathol Int. 2004;54(11):837–842. Scholar
  10. 10.
    Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, et al. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Renal Fail. 2008;30(6):611–6. Scholar
  11. 11.
    Diaz-Tejeiro R, Maduell F, Diez J, Esparza N, Errasti P, Purroy A, et al. Loss of renal graft due to recurrent IgA nephropathy with rapidly progressive course: an unusual clinical evolution. Nephron. 1990;54(4):341–3.CrossRefPubMedGoogle Scholar
  12. 12.
    Robles NR, Gomez Campdera FJ, Anaya F, Niembro De Rasche E, Galan A, Rengel MA, et al. IgA nephropathy with rapidly progressive course after kidney transplantation. Nephron. 1991;58(4):487–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis. Nephron. 1994;66(1):113–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Park SB, Joo I, Park KA, Cho WH, Park CH, Kim SP, et al. Rapidly progressive glomerulonephritis in a renal transplant with recurrent IgA nephropathy. Transpl Proc. 1996;28(3):1529–30.Google Scholar
  15. 15.
    Shimizu T, Tanabe K, Tokumoto T, Shimmura H, Koga S, Ishikawa N, et al. A case of rapid progressive glomerulonephritis with IgA deposits after renal transplantation. Clin Transpl. 2001;15(5):11–5.CrossRefGoogle Scholar
  16. 16.
    Benabdallah L, Rerolle JP, Peraldi MN, Noel LH, Bruneel MF, Carron PL, et al. An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. Am J Kidney Dis. 2002;40(6):E20. Scholar
  17. 17.
    Mousson C, Charon-Barra C, Funes de la Vega M, Tanter Y, Justrabo E, Martin L, et al. Recurrence of IgA nephropathy with crescents in kidney transplants. Transpl Proc. 2007;39(8):2595–6. Scholar
  18. 18.
    Gopalakrishnan N, Murugananth S, Dineshkumar T, Dhanapriya J, Sakthirajan R, Balasubramaniyan T. Two consecutive recurrences of crescentic immunoglobulin a nephropathy in a renal transplant recipient. Indian J Nephrol. 2016;26(5):376–8. Scholar
  19. 19.
    Herzog AL, Wanner C, Amann K, Lopau K. First treatment of relapsing rapidly progressive IgA nephropathy With Eculizumab after living kidney donation: a case report. Transpl Proc. 2017;49(7):1574–7. Scholar
  20. 20.
    Katsumata H, Yamamoto I, Komatsuzaki Y, Kawabe M, Okabayashi Y, Yamakawa T, et al. Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation. BMC Nephrol. 2018;19(1):64. Scholar
  21. 21.
    Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide) lines–application to the individual patient. Kidney Int. 2012;82(8):840–56. Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  1. 1.Department of NephrologyGeneral Hospital of LivadeiaLivadeiaGreece
  2. 2.Department of Nephrology“Evaggelismos” General Hospital of AthensAthensGreece
  3. 3.Department of Histopathology“Evaggelismos” General Hospital of AthensAthensGreece
  4. 4.“Mesogeios” Hemodialysis UnitHeraklionGreece

Personalised recommendations